First FGBIP Q1 2026 Beat Revenue NA EPS Exceeds by Significant Pacira BioSciences PCRX Q1 2026 Beat Revenue 72641100000 EPS Exceeds by Significant Launch One LPAA Pauses at 1076 After Recent Volatility 20260521 United Therapeutics UTHR Edges Higher as Stock Nears Key Resistance